Healthcare
Medline Inc.(MDLN)
Live Price
Offline$36.42
-1.81% today
Window Change
-11.17%
Window
Dec 17, 2025 โ Jun 17, 2026
- Market Cap
- $36.32B
- Revenue Growth
- +11.5%
- EPS Growth
- -5.9%
- Dividend Yield
- 0.0%
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 124 bars ยท Dec 17, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Medline Inc. (MDLN) is a Healthcare stock with a market cap of $36.32B and listed on NASDAQ. The stock last traded around $36.42 and down 11.2% across the available one-year price window (Dec 17, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of +11.5%, EPS growth of -5.9%, a dividend yield of 0.0%. What stands out right now is revenue +11.5%, EPS -5.9%, free cash flow +24.1% with operating margin 7.8% and ROIC 5.7%. Valuation already assumes a fairly strong business story at P/E 31.4 and price/sales 1.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines MDLN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+11.5% vs +7.6% peer median
Operating Margin
Below sector median
+7.8% vs +19.4% peer median
P/E
Below sector median
31.4 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 27, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +11.5% and EPS is at -5.9%, with operating margin around 7.8%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -2.3% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 27, 2026 | โ | +2.7% | -3.8% | โ |
2026 Feb 25, 2026 | -7.6% | +1.5% | -11.0% | -11.4% |
2025 Nov 4, 2025 | โ | -3.7% | +8.0% | +7.7% |
Benchmark Edge
MDLN vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
MDLN
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
MDLN Max Drawdown
-33.61%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for MDLN and SPY.
Company Overview
Medline Inc.
NASDAQ Global Select
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services such as, consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. Medline Inc. was founded in 1966 and is based in Northfield, Illinois.
- Leadership
- James Boyle
- IPO Date
- Dec 17, 2025
- Employees
- 43.0k
- Street Address
- 3 Lakes Drive
- Mailing
- Northfield, IL, 60093
- Region
- Northfield, IL, US
- Reporting Currency
- USD
- Investor Line
- (847) 949-5500
- Last Updated
- May 2, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 31.4
- EV/EBITDA
- 15.1
- Price/Sales
- 1.3
- Price/Book
- 3.4
Growth
- Revenue
- +11.5%
- EPS
- -5.9%
- Free Cash Flow
- +24.1%
Profitability
- Gross Margin
- 24.6%
- Operating Margin
- 7.8%
- Net Margin
- 4.1%
- ROE
- 7.6%
- ROIC
- 5.7%
Balance Sheet
- Debt/Equity
- 1.17
- Current Ratio
- 4.29
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.